The landscape of dementia prognosis has evolved substantially with the advent of advanced biomarkers, including amyloid PET scans, tau imaging, and blood-dependent tests which will detect Alzheimer's pathology many years right before signs arise. Though these technological improvements represent amazing development in knowing neurodegenerative diso